| Entry |
|
|---|
| Name |
Nitazoxanide (USAN/INN);
Alinia (TN)
|
|---|
| Product |
|
|---|
| Formula |
C12H9N3O5S
|
|---|
| Exact mass |
307.0263
|
|---|
| Mol weight |
307.282
|
|---|
| Structure |
   |
|---|
| Remark |
|
|---|
| Efficacy |
Antiprotozoal |
|---|
| Disease |
Diarrhea caused by Giardia lamblia [DS: H00362] Diarrhea caused by Cryptosporidium parvum [DS: H00356] |
|---|
| Comment |
Treatment of Cryptosporidium parvum and Giardia lamblia
Salicylanilide derivative
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P01 ANTIPROTOZOALS
P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
P01AX Other agents against amoebiasis and other protozoal diseases
P01AX11 Nitazoxanide
D02486 Nitazoxanide (USAN/INN) <US>
USP drug classification [BR:br08302]
Antiparasitics
Antiprotozoals
Nitazoxanide
D02486 Nitazoxanide (USAN/INN)
Antiinfectives [br08350.html]
Antiparasitics
D02486
New drug approvals in the USA [br08319.html]
New Molecular Entity and New Therapeutic Biological Product Approvals
D02486
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02486
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
| KCF data |
ATOM 21
1 C8y C 16.1700 -19.6000
2 N1b N 17.3600 -18.9000
3 C5a C 18.5500 -19.6000
4 C8y C 19.7400 -18.9000
5 S2x S 14.9800 -18.7600
6 C8y C 13.9300 -19.6000
7 C8x C 14.3500 -20.9300
8 N5x N 15.7500 -21.0000
9 N2b N 12.7400 -18.9000 #+
10 O3a O 11.4100 -19.7400 #-
11 O3a O 12.7400 -17.5700
12 O5a O 18.5500 -21.0000
13 C8y C 19.7400 -17.5000
14 C8x C 20.9300 -19.6000
15 C8x C 22.1200 -18.9000
16 C8x C 22.1200 -17.5000
17 C8x C 20.9300 -16.8000
18 O7a O 18.5247 -16.8049
19 C7a C 18.5189 -15.4003
20 O6a O 17.3271 -14.7185
21 C1a C 19.7516 -14.6816
BOND 22
1 1 2 1
2 2 3 1
3 3 4 1
4 1 5 1
5 5 6 1
6 6 7 2
7 7 8 1
8 1 8 2
9 6 9 1
10 9 10 1
11 9 11 2
12 3 12 2
13 4 13 1
14 4 14 2
15 14 15 1
16 15 16 2
17 16 17 1
18 13 17 2
19 13 18 1
20 18 19 1
21 19 20 2
22 19 21 1
|
|---|
